Der positive Einfluss von Omega-3-Fettsäuren auf Entzündungsprozesse und Parodontitis

Lernziele

Nach dem Durcharbeiten dieses Beitrags sollten Sie in der Lage sein,

• die physiologischen Wirkmechanismen von Omega-3-Fettsäuren im Rahmen von Entzündungsprozessen zu kennen,

• die Möglichkeit des Einsatzes von Omega-3-Fettsäuren als Adjuvans in der Parodontitistherapie abschätzen zu können,

• Patienten mit Parodontitis bzgl. einer Ernährung, die reich an Omega-3-Fettsäuren ist, zu beraten.

• Literatur

• 1 Peters-Golden M, Brock TG. 5-lipoxygenase and FLAP. Prostaglandines Leukot Essent Fatty Acids. 2003; 69: 99-109
• 2 Busch L, Miozza V, Sterin-Borda L et al. Increased leukotriene concentration in submandibular glands from rats with experimental periodontitis. Inflamm Res 2009; 58: 423-430
• 3 Pradeep AR, Manjunath SG, Swati PP et al. Gingival crevicular fluid levels of leukotriene B4 in periodontal health and disease. J Periodontol 2007; 78: 2325-2330
• 4 Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997; 14: 112-143
• 5 Noguchi K, Shitashige M, Endo H et al. Binary regulation of interleukin (IL)-6 production by EP1 and EP2 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. J Periodontal Res 2002; 37: 29-36
• 6 Belibasakis GN, Guggenheim B. Induction of prostaglandin E2 and interleukin-6 in gingival fibroblasts by oral biofilms. FEMS Immunol Med Microbiol 2011; 63: 381-386
• 7 Weinberg E, Zeldich E, Weinreb MM et al. Prostaglandin E2 inhibits the proliferation of human gingival fibroblasts via the EP2 receptor and Epac. J Cell Biochem 2009; 108: 207-215
• 8 Kumar AK, Reddy NR, Babu M et al. Estimation of prostaglandin E2 levels in gingival crevicular fluid in periodontal health, disease and after treatment. Contemp Clin Dent 2013; 4: 303-306
• 9 Goldhaber P, Rabadjija L, Beyer WR et al. Bone resorption in tissue culture and its relevance to periodontal disease. J Am Dent Assoc 1973; 87: 1027-1033
• 10 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013; 63: 149-164
• 11 Odusanwo O, Chinthamani S, McCall A et al. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol 2012; 302: 1331-1345
• 12 Hasturk H, Kantarci A, Goguet-Surmenian E et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007; 179: 7021-7029
• 13 Schwab JM, Chiang N, Arita M et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007; 447: 869-874
• 14 Fredman G, Oh SF, Ayilavarapu S et al. Impaired phagocytosis in Localized aggressive periodontitis: rescue by resolving E1. PloS One 2011; 6
• 15 Herrera BS, Ohira T, Gao L et al. An endogenous regulator of inflammation, resolving E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008; 155: 1214-1223
• 16 Biesalski HK, Fürst P, Kasper H et al. -3-Fettsäuren. In: Ernährungsmedizin. 2. überarbeitete Auflage. Stuttgart: Thieme Verlag; 1999: 80-82
• 17 Bullon P, Battino M, Varela-Lopez A et al. Diets based on virgin olive oil or fish oil but not on sunflower oil prevent age-related alveolar bone resorption by mitochondrial-related mechanisms. PloS One 2013; 8
• 18 Bendyk A, Marino V, Zilm PS et al. Effect of dietary omega-3-polyunsaturated fatty acids on experimental periodontits in mouse. J Periodont Res 2009; 44: 211-216
• 19 Kesavalu L, Vasudevan B, Raghu B et al. Omega-3 fatty acid effect on alveolar bone loss in rats. J Dent Res 2006; 85: 648-652
• 20 Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 2008; 214: 201-209
• 21 Campan P, Planchand PO, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol 1997; 24: 907-913
• 22 Martinez GL, Koury JC, Brito F et al. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trail. J Periodontol Res (im Druck) 2013;
• 23 Rosenstein ED, Kushner LJ, Kramer N et al. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 2003; 68: 213-218
• 24 Eberhard J, Heilmann F, Acil Y et al. Local application of n-3 or n-6 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol 2002; 29: 364-369
• 25 El-Sharkawy H, Aboelsaad N, Eliwa M et al. Adjunctive treatment of chronic periodontitis with daily diary supplementation with omega-3-fatty acids and low-dose aspirin. J Periodontol 2010; 81: 1635-1643
• 26 Fiqueredo CM, Martinez GL, Koury JC et al. Serum levels of long-chain polyunsaturated fatty acids in patients with periodontal disease. J Periodontol 2013; 84: 675-682
• 27 Naqvi AZ, Buettner C, Phillips RS et al. N-3 fatty acids and periodontitis in US adults. J Am Diet Assoc 2010; 110: 1669-1675
• 28 Brenna JT, Salem N, Sinclair AJ et al. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 85-91
• 29 Alessandri JM, Guesnet P, Vancassel S et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 2004; 44: 509-538
• 30 Jeffrey BG, Weisinger HS, Neuringer M et al. The role of docosahexaenoic acid in retinal function. Lipids 2001; 36: 859-871